Literature DB >> 21633026

Endemic tegumentary leishmaniasis in Brazil: correlation between level of endemicity and number of cases of mucosal disease.

Sandro J Bedoya-Pacheco1, Maria H Araujo-Melo, Claudia M Valete-Rosalino, Maria Inês F Pimentel, Fátima Conceição-Silva, Armando O Schubach, Mauro C A Marzochi.   

Abstract

The purpose of this study was to establish a correlation between the endemic level of tegumentary leishmaniasis in different regions of Brazil during 2002-2009 and the number of cases of mucosal or mucocutaneous leishmaniasis. The proportion of mucosal leishmaniasis was inversely correlated with prevalence of infection. In areas with a lower infection prevalence, the proportion of mucosal leishmaniasis increased (P < 0.05). The hypothesis of an Amazonian origin and dissemination through human migration is considered. Our results show that in regions with lower prevalence and endemically younger, the proportion of cases that evolve to the mucosal form is higher than in regions with higher prevalence and endemically older.

Entities:  

Mesh:

Year:  2011        PMID: 21633026      PMCID: PMC3110350          DOI: 10.4269/ajtmh.2011.10-0595

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  29 in total

1.  American cutaneous leishmaniasis in Southeast Brazil: space-time clustering.

Authors:  G L Machado-Coelho; R Assunção; W Mayrink; W T Caiaffa
Journal:  Int J Epidemiol       Date:  1999-10       Impact factor: 7.196

2.  Monophyletic origin of the genus Leishmania Ross, 1903.

Authors:  V Thomaz-Soccol; G Lanotte; J A Rioux; F Pratlong; A Martini-Dumas; E Serres
Journal:  Ann Parasitol Hum Comp       Date:  1993

3.  kDNA minicircle signatures of Leishmania (Viannia) braziliensis in oral and nasal mucosa from mucosal leishmaniasis patients.

Authors:  Fernanda Santos de Oliveira; Cláudia Maria Valete-Rosalino; Armando de Oliveira Schubach; Raquel da Silva Pacheco
Journal:  Diagn Microbiol Infect Dis       Date:  2010-04       Impact factor: 2.803

4.  Leishmania (Viannia): genetic analysis of cutaneous and mucosal strains isolated from the same patient.

Authors:  Patricia Cuervo; Elisa Cupolillo; Nedia Nehme; Vivian Hernandez; Nancy Saravia; Octavio Fernandes
Journal:  Exp Parasitol       Date:  2004 Sep-Oct       Impact factor: 2.011

5.  Wild and synanthropic hosts of Leishmania (Viannia) braziliensis in the endemic cutaneous leishmaniasis locality of Amaraji, Pernambuco State, Brazil.

Authors:  Sinval P Brandão-Filho; Maria E Brito; Francisco G Carvalho; Edna A Ishikawa; Elisa Cupolillo; Lucile Floeter-Winter; Jeffrey J Shaw
Journal:  Trans R Soc Trop Med Hyg       Date:  2003 May-Jun       Impact factor: 2.184

6.  Primary laryngeal leishmaniasis: a rare case report.

Authors:  Bipin Kumar; Anand Ghimire; Smriti Karki; Paricha Upadhyaya
Journal:  Indian J Pathol Microbiol       Date:  2009 Jan-Mar       Impact factor: 0.740

7.  Leishmania (Viannia) braziliensis genotypes identified in lesions of patients with atypical or typical manifestations of tegumentary leishmaniasis: evaluation by two molecular markers.

Authors:  C Baptista; A O Schubach; M F Madeira; C A Leal; M Q Pires; F S Oliveira; F Conceição-Silva; C M V Rosalino; M M Salgueiro; R S Pacheco
Journal:  Exp Parasitol       Date:  2008-12-16       Impact factor: 2.011

8.  [On the origin and spread of cutaneous and mucosal leishmaniasis, based on pre- and post- colombian historical source].

Authors:  Alfredo J Altamirano-Enciso; Mauro C A Marzochi; João S Moreira; Armando O Schubach; Keyla B F Marzochi
Journal:  Hist Cienc Saude Manguinhos       Date:  2003 Sep-Dec

Review 9.  Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis.

Authors:  Albert Schriefer; Mary E Wilson; Edgar M Carvalho
Journal:  Curr Opin Infect Dis       Date:  2008-10       Impact factor: 4.915

10.  Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure.

Authors:  A Schubach; M C Marzochi; T Cuzzi-Maya; A V Oliveira; M L Araujo; A L Oliveira; R S Pacheco; H Momen; F Conceicao-Silva; S G Coutinho; K B Marzochi
Journal:  Am J Trop Med Hyg       Date:  1998-06       Impact factor: 2.345

View more
  5 in total

1.  The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas.

Authors:  Kristina M Bacon; Peter J Hotez; Stephanie D Kruchten; Shaden Kamhawi; Maria Elena Bottazzi; Jesus G Valenzuela; Bruce Y Lee
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

2.  Population structure and evidence for both clonality and recombination among Brazilian strains of the subgenus Leishmania (Viannia).

Authors:  Katrin Kuhls; Elisa Cupolillo; Soraia O Silva; Carola Schweynoch; Mariana Côrtes Boité; Maria N Mello; Isabel Mauricio; Michael Miles; Thierry Wirth; Gabriele Schönian
Journal:  PLoS Negl Trop Dis       Date:  2013-10-31

3.  Patterns of migration and risks associated with leprosy among migrants in Maranhão, Brazil.

Authors:  Christine Murto; Frédérique Chammartin; Karolin Schwarz; Lea Marcia Melo da Costa; Charles Kaplan; Jorg Heukelbach
Journal:  PLoS Negl Trop Dis       Date:  2013-09-05

4.  Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013).

Authors:  Lucia Regina Brahim; Cláudia Maria Valete-Rosalino; Liliane de Fátima Antônio; Maria Inês Fernandes Pimentel; Marcelo Rosandiski Lyra; Luiz Eduardo de Carvalho Paes; Ananda Dutra da Costa; Iracema Forni Vieira; Cristina Maria Giordano Dias; Maria Cristina de Oliveira Duque; Mauro Celio de Almeida Marzochi; Armando de Oliveira Schubach
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-12       Impact factor: 2.743

5.  Burden of leishmaniasis in Brazil and federated units, 1990-2016: Findings from Global Burden of Disease Study 2016.

Authors:  Juliana Maria Trindade Bezerra; Valdelaine Etelvina Miranda de Araújo; David Soeiro Barbosa; Francisco Rogerlândio Martins-Melo; Guilherme Loureiro Werneck; Mariângela Carneiro
Journal:  PLoS Negl Trop Dis       Date:  2018-09-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.